APA (7th ed.) Citation

Z, K., JP, S., I, K., T, S., R, E., G, O., . . . G, T. (2024). 52Mn-labelled Beta-cyclodextrin for Melanoma Imaging: A Proof-of-concept Preclinical Study. In vivo (Athens, Greece), 38(6), 2591. https://doi.org/10.21873/invivo.13735

Chicago Style (17th ed.) Citation

Z, Képes, et al. "52Mn-labelled Beta-cyclodextrin for Melanoma Imaging: A Proof-of-concept Preclinical Study." In Vivo (Athens, Greece) 38, no. 6 (2024): 2591. https://doi.org/10.21873/invivo.13735.

MLA (9th ed.) Citation

Z, Képes, et al. "52Mn-labelled Beta-cyclodextrin for Melanoma Imaging: A Proof-of-concept Preclinical Study." In Vivo (Athens, Greece), vol. 38, no. 6, 2024, p. 2591, https://doi.org/10.21873/invivo.13735.